Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use LATANOPROSTENE BUNOD OPHTHALMIC SOLUTION safely and effectively. See full prescribing information for LATANOPROSTENE BUNOD OPHTHALMIC SOLUTION. LATANOPROSTENE BUNOD ophthalmic solution. Initial U.S. Approval: 2017
Medication labelWhy this: Advisory · dailymed-prescription
Latanoprostene bunod ophthalmic solution, 0.024% is indicated for the reduction of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension.
- generic_name
- latanoprostene bunod ophthalmic solution, 0.024%
- product_names
- Latanoprostene Bunod Ophthalmic Solution, 0.024%
- ndc
- 68083-563, 68083-564, 68083-563-01, 68083-564-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en